Merck & Co., Inc. (MRK) key performance indicators and operating metrics (28 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Keytruda revenue | 8.03B | FY2026-Q1 |
| Lenvima alliance revenue | 256M | FY2026-Q1 |
| GARDASIL/GARDASIL 9 sales | 1.07B | FY2026-Q1 |
| Animal Health Sales | 1.79B | FY2026-Q1 |
| Total Worldwide Sales | 16.29B | FY2026-Q1 |
| Bridion sales | 472M | FY2026-Q1 |
| Pharmaceutical Sales | 14.35B | FY2026-Q1 |
| PREVYMIS Sales | 272M | FY2026-Q1 |
| Winrevair global sales | 525M | FY2026-Q1 |
| WELIREG Sales | 199M | FY2026-Q1 |
| Capvaxive sales | 142M | FY2026-Q1 |
| Januvia sales | 574M | FY2026-Q1 |
| OHTUVAYRE Sales | 131M | FY2026-Q1 |
| Lynparza alliance revenue | 389M | FY2025-Q4 |
Back to MRK overview · MRK earnings · MRK holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.